CA Patent

CA2563192A1 — Tri(cyclo) substituted amide compounds

Assigned to Prosidion Ltd · Expires 2005-11-03 · 21y expired

What this patent protects

Compounds of Formula (I) or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.

USPTO Abstract

Compounds of Formula (I) or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.

Drugs covered by this patent

Patent Metadata

Patent number
CA2563192A1
Jurisdiction
CA
Classification
—
Expires
2005-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Prosidion Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.